Stimulated human leukocytes cause activating mutations in the K-ras proto-oncogene

被引:0
|
作者
Janis Harline Jackson
Maya Vollenweider
Jennifer Hill
Henry Rodriguez
Alan W Schwabacher
Gopa Mitra
Chao-Yu Kuo
机构
[1] The Scripps Research Institute,Department of Immunology
[2] Princeton University,Department of Chemistry
[3] Promega Corporation,undefined
来源
Oncogene | 1997年 / 14卷
关键词
inflammation; carcinogenesis; oxidants; DNA damage; K-ras;
D O I
暂无
中图分类号
学科分类号
摘要
Human tissues which are chronically infiltrated with inflammatory leukocytes are more likely to develop malignancies than non-inflamed tissues, however the mechanism(s) by which leukocytes contribute to carcinogenesis is unknown. Stimulated human leukocytes release superoxide anion and hydrogen peroxide which, in the presence of iron, can be converted into the potent oxidant, hydroxyl radical (•OH). Previous studies have shown that leukocyte-derived •OH (or a •OH-like species) can cause DNA damage, however a relationship between leukocyte-induced DNA damage and carcinogenesis has not been established. The present report demonstrates that leukocyte-derived •OH-induced DNA damage can cause K-ras oncogene activation, and suggests that there may be a characteristic pattern of •OH-induced K-ras oncogene activation. Since activation of the K-ras oncogene is believed to play a crucial role in the pathogenesis of many human malignancies, •OH-induced K-ras oncogene activation could be an important mechanism by which human leukocytes contribute to carcinogenesis.
引用
收藏
页码:2803 / 2808
页数:5
相关论文
共 50 条
  • [41] PROTO-ONCOGENE ABNORMALITIES IN HUMAN CANCER
    CLINE, MJ
    CLINICAL CHEMISTRY, 1989, 35 (06) : 1057 - 1057
  • [42] Differential network reprogramming by distinct activating K-Ras mutations
    Hammond, Dean E.
    Mageean, Craig J.
    Rusilowicz, Emma V.
    Clague, Michael J.
    Prior, Ian A.
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [43] The RET proto-oncogene in human cancers
    Jhiang, SM
    ONCOGENE, 2000, 19 (49) : 5590 - 5597
  • [44] SPONTANEOUS ACTIVATION OF A HUMAN PROTO-ONCOGENE
    SANTOS, E
    REDDY, EP
    PULCIANI, S
    FELDMANN, RJ
    BARBACID, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (15): : 4679 - 4683
  • [45] The RET proto-oncogene in human cancers
    Sissy M Jhiang
    Oncogene, 2000, 19 : 5590 - 5597
  • [46] Analysis of K-ras oncogene mutations in chronic pancreatitis with ductal hyperplasia
    Rivera, JA
    Rall, CJN
    GraemeCook, F
    FernandezdelCastillo, C
    Shu, P
    Lakey, N
    Tepper, R
    Rattner, DW
    Warshaw, AL
    Rustgi, AK
    SURGERY, 1997, 121 (01) : 42 - 49
  • [47] K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas
    Bartsch, D
    Bastian, D
    Barth, P
    Schudy, A
    Nies, C
    Kisker, O
    Wagner, HJ
    Rothmund, M
    ANNALS OF SURGERY, 1998, 228 (01) : 79 - 86
  • [48] DETECTION OF POINT MUTATIONS IN K-RAS ONCOGENE IN LUNG-CANCER
    HACKMAN, P
    HUSGAFVELPURSIAINEN, K
    ANTTILA, S
    RIDANPAA, M
    KARJALAINEN, A
    HEIKKILA, L
    VAINIO, H
    MUTATION RESEARCH, 1991, 252 (02): : 203 - 203
  • [49] K-RAS ONCOGENE CODON 12 POINT MUTATIONS IN TESTICULAR CANCER
    RIDANPAA, M
    LOTHE, RA
    ONFELT, A
    FOSSA, S
    BORRESEN, AL
    HUSGAFVELPURSIAINEN, K
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1993, 101 : 185 - 187
  • [50] Variability of Ha-ras (codon 12) proto-oncogene mutations in diverse thyroid cancers
    Bouras, M
    Bertholon, J
    Dutrieux-Berger, N
    Parvaz, P
    Paulin, C
    Revol, A
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 139 (02) : 209 - 216